Avience Biomedicals Limited IPO GMP Today
Live grey market premium data. For informational purposes only.
Grey Market Premium
Premium per share over the upper price band
- Est. listing price
- ₹353
- Upper price band
- ₹208
GMP is an unofficial grey-market indicator, not a guarantee of listing price. Not investment advice.
GMP history
Day-by-day grey market premium for Avience Biomedicals Limited
- Highest
- ₹145
- Lowest
- ₹50
- Readings
- 9 days
| Date | GMP | Change | Est. listing |
|---|---|---|---|
| 25 Jun 2026 | ₹145 | ▲ ₹45 | ₹353(+69.71%) |
| 24 Jun 2026 | ₹100 | ▲ ₹17 | ₹308(+48.08%) |
| 23 Jun 2026 | ₹83 | ▲ ₹13 | ₹291(+39.9%) |
| 22 Jun 2026 | ₹70 | no change | ₹278(+33.65%) |
| 21 Jun 2026 | ₹70 | ▼ ₹15 | ₹278(+33.65%) |
| 18 Jun 2026 | ₹85 | ▲ ₹10 | ₹293(+40.87%) |
| 17 Jun 2026 | ₹75 | ▼ ₹18 | ₹283(+36.06%) |
| 16 Jun 2026 | ₹93 | ▲ ₹43 | ₹301(+44.71%) |
| 15 Jun 2026 | ₹50 | — | ₹258(+24.04%) |
Grey market premium is an unofficial indicator quoted by private dealers. It is not published by the company, SEBI, NSE or BSE, and it does not predict the listing price. Not investment advice.
Price band: ₹196 – ₹208
Est. listing price: ₹353
Premium: 69.71%
Frequently asked questions
What is the Avience Biomedicals Limited IPO GMP today?
The latest grey market premium recorded for Avience Biomedicals Limited is ₹145, as of 25-Jun-2026. Against the upper price band of ₹208 that points to an estimated listing price of ₹353, a premium of 69.71%. GMP is an unofficial figure quoted by private dealers, not published by the company or the exchanges.
Does GMP decide the listing price?
No. Grey market premium reflects what a small, unregulated market is willing to pay before listing. The listing price is set by the exchange call auction on listing day and regularly differs from the premium, in both directions.
How often is Avience Biomedicals Limited GMP updated here?
Readings are refreshed through the day while the issue is open and are recorded day by day in the history table on this page, so the trend is visible rather than just the latest number.
← Back to Avience Biomedicals Limited IPO details
GMP is unofficial market data. Not investment advice.